97925396 - ELEVIDYS

Information

• Trademark
• 97925396

• Source

• Serial Number

  97925396

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 41 - Education
  • 44 - Medical services

• Filing Date

  May 08, 2023
  a year ago

• Transaction Date

  April 23, 2024
  a month ago

• Status Date

  January 31, 2024
  4 months ago

• Location Date

  January 31, 2024
  4 months ago

• Status Code

  641

• Current Location

  TMO LAW OFFICE 115 - EXAMINING ATTORNEY ASSIGNED

  Employee Name

  CHANG, ELIZABETH YI HS

• Attorney Name

  Maury M. Tepper, III

  Law Office Assigned Location Code

  M60

• Owners

  • SAREPTA THERAPEUTICS, INC.

Case File Statements

• GS0411: Medical training and teaching
• DM0000: The mark consists of three alternately-shaded semi-circles increasing in size to an oval center and three alternately-shaded semi-circles decreasing in size on the other side of the oval center and followed by 'Elevidys.' The color gray is intended to show shading or contract only.
• GS0051: Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapies for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases
• CC0000: Color is not claimed as a feature of the mark.
• GS0441: Medical services; providing health information

Case File Event Statements

• 5/11/2023 - a year ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 6/6/2023 - 12 months ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 6/7/2023 - 11 months ago

  3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC

• 1/31/2024 - 4 months ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 1/31/2024 - 4 months ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 1/31/2024 - 4 months ago

  6 - NON-FINAL ACTION E-MAILED Type: GNRT

• 1/31/2024 - 4 months ago

  7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 4/23/2024 - a month ago

  8 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR

• 4/23/2024 - a month ago

  9 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG